Results support further development of V-212 independently and in combination with approved pneumococcal conjugate vaccines (PCVs) Virometix AG, a clinical-stage biotechnology company pioneering fully ...
Virometix AG Announces Completion of $15 Million Financing Round to Advance Development of V-212 and Next-Generation Synthetic Vaccines Virometix AG, a clinical-stage biotechnology company pioneering ...
PLYMOUTH MEETING, Pennsylvania (WPVI) -- There are at least four research groups already working around-the-clock to create a vaccine for the Wuhan coronavirus. One developed in the Philadelphia area ...
In the realm of medical advancements, a universal vaccine that can protect against any pathogen has long been a Holy ...
As the global spread of the Zika virus continues, efforts are underway to halt the disease's transmission. While no licensed therapies or vaccines to protect against the Zika virus are currently ...
A novel synthetic DNA vaccine can, for the first time, induce protective immunity against the Middle East Respiratory Syndrome (MERS) coronavirus in animal species, reported researchers from the ...
In 2021, a group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell Medicine and NewYork-Presbyterian reported that the Moderna mRNA vaccine and a ...
Researchers at University of California San Diego School of Medicine have found that a natural fungal supplement taken at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results